USPTO 2015–2025 USPTO PatentsView US Corporation

DeRoyal Industries, Inc.

USPTO PatentsView assignee record - 89 granted patents across 25 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Deroyal ranks #4,037 of 49,997 tracked US assignees by granted-patent volume, with 89 patents across 25 technology areas.

#4,037
of 49,997 US assignees by volume
Top 8%
by Innovation Score (54.1/100)
7.0
avg claims per patent
+194%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4037 · US Corporation #4,037 · 89 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-SPARSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 89 grants
  • TOP-DECILE #4,037/49,997
  • PHOTO-FINISH Carbo Ceramics
  • CPC-FOCUS A61F · 25 areas
  • INNOV-PAR 54.1/100
  • CLAIMS-SPARSE 7.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +194% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Carbo Ceramics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Deroyal’s 54.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Deroyal

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Deroyal's Innovation Score is 54.1/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Deroyal?

Each dot is one of Deroyal’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Deroyal’s own 7.0 claims/patent is at or below the 12.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Deroyal vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 88.989.089.08989.089.089.1 051015202530 Granted patents (volume) Avg claims / patent Carbo Ceramics, Inc. - 89, 19.01Carbo CeramicsCollins Engine Nozzles, Inc. - 89, 12.63Collins Engine No…Columbia Sportswear North America, Inc. - 89, 3.37Columbia Sportswe…Duelight LLC - 89, 25.22DuelightDentsply International Inc. - 89, 11.29Dentsply Internat…Diodes Incorporated - 89, 15.99Diodes Incorporat…Eizo Corporation - 89, 9.84EizoFaurecia Systemes D'echappement - 89, 16.1Faurecia Systemes…DeRoyal Industries, Inc. - 89, 6.99Deroyal Industries
Deroyal vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Deroyal's grants concentrate

DeRoyal Industries, Inc. is a focused PatentsView assignee: 25 CPC subclasses with 29.2% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (19 grants) versus a trough of 1 in 2015. By volume, Deroyal sits between Carbo Ceramics, Inc. and Faurecia Systemes D'echappement.

Deroyal's three-year grant acceleration

DeRoyal Industries, Inc. shows 40 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at DeRoyal's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows DeRoyal holds 89 patents at rank #4,037, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near DeRoyal

By rank, the assignees closest to #4,037 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in DeRoyal's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for DeRoyal, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), DeRoyal ranks #250 of 3,082 assignees by patent count in that subclass.

Deroyal's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20152016201720182019202020212022202320242025 18
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
DeRoyal Industries, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 1.1%
2016 5 5.6%
2017 2 2.2%
2018 7 7.9%
2019 3 3.4%
2020 3 3.4%
2021 10 11.2%
2022 8 9.0%
2023 19 21.3%
2024 13 14.6%
2025partial year 18 20.2%

Which technologies does DeRoyal Industries, Inc. patent most?

Top 15 of 25 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

DeRoyal Industries, Inc.'s patent record in context - here's where to go next.

  • DeRoyal Industries, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 29.2% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #4,037 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare DeRoyal Industries, Inc. against Carbo Ceramics, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 54.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.